Compile Data Set for Download or QSAR
Report error Found 18 Enz. Inhib. hit(s) with all data for entry = 50044940
TargetCytochrome P450 2D6(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037205(CHEMBL3356239)
Affinity DataIC50: 370nMAssay Description:Inhibition of human recombinant CYP2D6 after 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037212(CHEMBL3356251)
Affinity DataIC50: 600nMAssay Description:Inhibition of human recombinant CYP2D6 after 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037205(CHEMBL3356239)
Affinity DataIC50: 3.00E+3nMAssay Description:Inhibition of human recombinant CYP2C19 after 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50383961(CHEMBL2031958)
Affinity DataIC50: 3.40E+3nMAssay Description:Inhibition of human ERG expressed in CHO cells by Rb efflux assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037205(CHEMBL3356239)
Affinity DataIC50: 4.80E+3nMAssay Description:Inhibition of human recombinant CYP2C9 after 45 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037205(CHEMBL3356239)
Affinity DataIC50: 8.30E+3nMAssay Description:Inhibition of human ERG expressed in CHO cells by Rb efflux assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037205(CHEMBL3356239)
Affinity DataIC50: 2.60E+4nMAssay Description:Inhibition of human recombinant CYP1A2 after 15 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037208(CHEMBL3356246)
Affinity DataIC50: 2.60E+4nMAssay Description:Inhibition of human ERG expressed in CHO cells by Rb efflux assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037209(CHEMBL3356247)
Affinity DataIC50: 4.61E+4nMAssay Description:Inhibition of human ERG expressed in CHO cells by Rb efflux assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037212(CHEMBL3356251)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human recombinant CYP2C19 after 30 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037212(CHEMBL3356251)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human recombinant CYP2C9 after 45 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037212(CHEMBL3356251)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of human recombinant CYP1A2 after 15 minsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037211(CHEMBL3356249)
Affinity DataIC50: 5.01E+4nMAssay Description:Inhibition of human ERG expressed in CHO cells by Rb efflux assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037207(CHEMBL3356242)
Affinity DataIC50: 5.47E+4nMAssay Description:Inhibition of human ERG expressed in CHO cells by Rb efflux assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037213(CHEMBL3356252)
Affinity DataIC50: 7.60E+4nMAssay Description:Inhibition of human ERG expressed in CHO cells by Rb efflux assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037210(CHEMBL3356248)
Affinity DataIC50: 7.86E+4nMAssay Description:Inhibition of human ERG expressed in CHO cells by Rb efflux assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037212(CHEMBL3356251)
Affinity DataIC50: 9.80E+4nMAssay Description:Inhibition of human ERG expressed in CHO cells by Rb efflux assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
Astellas Pharma

Curated by ChEMBL
LigandPNGBDBM50037206(CHEMBL3356240)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of human ERG expressed in CHO cells by Rb efflux assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/15/2016
Entry Details Article
PubMed